The Renal Center

Filter Your Results

 

News

 

Endografts With Suprarenal Versus Infrarenal Fixation Compared for Renal Complications

July 6, 2017 -- A study comparing renal complications between endografts with suprarenal or infrarenal fixation was published by Sara L. Zettervall, MD, et al in European Jour…

Study Identifies Predictors of Renal Dysfunction After AAA Repair

April 19, 2017 -- A study of the predictors of renal complications after endovascular aneurysm repair (EVAR) and open repair of abdominal aortic aneurysms (AAAs) was published…

Study Evaluates EVAR Using Fenestrated-Branch Endografts Based on Supraceliac Sealing Zones

April 20, 2017 -- Gustavo S. Oderich, MD, et al conducted a prospective, nonrandomized study to evaluate manufactured fenestrated-branched endovascular aortic repair (EVA…

Temporal Trends in Peripheral Artery Interventions Analyzed in BMC2 PVI Registry

April 6, 2017 -- Findings from a study that aimed to examine trends in procedural indications, arterial beds treated, and device usage in peripheral artery interventions were …

Midterm Results Reported for Physician-Modified Endovascular Grafts to Treat Juxtarenal Aortic Aneurysms

February 1, 2017 -- In the Journal of Vascular Surgery (JVS), Benjamin W. Starnes, MD, et al published the midterm results from an ongoing physician-sponsored investigational …

New Data on TVA Medical’s everlinQ endoAVF System for Endovascular Hemodialysis Access Presented at LINC 2017

January 26, 2017 -- TVA Medical, Inc. announced that data from several studies on the company’s everlinQ endoAVF System, an endovascular technique to create hemodialysis…

Medtronic to Begin IDE Study for In.Pact Admiral DCB AV Fistula Indication

January 26, 2017 -- Medtronic announced it has received an investigational device exemption from the US Food and Drug Administration (FDA) to commence a new study of its In.Pa…

ReCor Medical Updates Progress in Trials for Paradise Renal Denervation System

November 2, 2016 -- ReCor Medical, Inc. recently announced key milestones in its RADIANCE-HTN clinical trial to evaluate the effect of the ReCor Paradise renal denervatio…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.